Mark W. Brunvand
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Hematology top 10%
- Co-authors
- Mark GroudineAnton KrummTea MeuliaClaudio AnasettiPatrick TanJohn A. HansenP S LinsleyJ Bradshaw
- Topics
- Lymphoma Diagnosis and Treatment (10 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)HER2/EGFR in Cancer Research (5 papers)
- Cited by
- ImmunologyHematologyOncology
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Mark W. Brunvand
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Immunology 554
- Molecular Biology 375
- Oncology 293
- Pathology and Forensic Medicine 176
- Hematology 126
Countries citing papers authored by Mark W. Brunvand
This map shows the geographic impact of Mark W. Brunvand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Brunvand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Brunvand more than expected).
Fields of papers citing papers by Mark W. Brunvand
This network shows the impact of papers produced by Mark W. Brunvand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Brunvand. The network helps show where Mark W. Brunvand may publish in the future.
Co-authorship network of co-authors of Mark W. Brunvand
This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Brunvand. A scholar is included among the top collaborators of Mark W. Brunvand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Brunvand. Mark W. Brunvand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 65 | |
| 4 | 27 | |
| 5 | 24 | |
| 6 | 18 | |
| 7 | 22 | |
| 8 | 13 | |
| 9 | 11 | |
| 10 | 47 | |
| 11 | 10 | |
| 12 | 47 | |
| 13 | 11 | |
| 14 | 52 | |
| 15 | Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies. | 39 |
| 16 | 433 | |
| 17 | 28 | |
| 18 | 235 | |
| 19 | 29 | |
| 20 | 48 |
About Mark W. Brunvand
Mark W. Brunvand is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Immunology (554 citations), Hematology (126 citations) and Oncology (293 citations). Mark W. Brunvand has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Mark Groudine, Anton Krumm, Tea Meulia, Claudio Anasetti, Patrick Tan, John A. Hansen, P S Linsley, J Bradshaw, J A Ledbetter and Jennifer Melrose. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.